BPC-157 10MG
Find your strength. Choose your bundle.
88 in stock
Earn up to $3.86 back on this itemLazarus Pass · 1–5% store credit + free shipping protection · A$19.95/moA closer
look.
BPC-157 (Body Protection Compound-157) — also written BPC 157 or BPC157 — is a synthetic pentadecapeptide based on a partial sequence identified in gastric-juice proteins.
In controlled laboratory research it is studied for its influence on angiogenic and cytoprotective signalling pathways in cell and tissue models.
Research details & references
Last reviewed:
Lazarus Labs supplies BPC-157 in Australia as a 10 mg lyophilised reference material at ≥ 99 % purity, with a certificate of analysis for every lot. For research use only — not for human or veterinary use.
What is BPC-157?
Research context
BPC-157 is a stable synthetic peptide examined in preclinical and in-vitro research into angiogenic and cytoprotective pathways in model systems. Because of that stability it is often selected as a consistent reference material for such studies. It is supplied strictly for laboratory research.
Specifications
- Presentation: 10 mg per vial
- Purity: ≥ 99 %, confirmed by HPLC and LC-MS
- Form: white lyophilised powder
- Solubility: readily soluble in water (H₂O)
- Testing: every batch independently tested by Janoshik (HPLC + LC-MS)
- Documentation: third-party certificate of analysis per lot
- Intended use: in-vitro and laboratory research only
Quality & documentation
Every lot is independently tested by Janoshik Analytical, with a certificate of analysis reporting HPLC purity and LC-MS identity for your exact batch. For deeper background, see our BPC-157 research overview.
Handling & storage
Store sealed and dry at 2–8 °C. After reconstitution, keep refrigerated and follow your laboratory’s own handling and stability procedures. BPC-157 is supplied for research use only and is not for human or veterinary use.
Dispatch & supply in Australia
BPC-157 ships from within Australia with tracked delivery, and every order includes the matching certificate of analysis.
Read the citation-backed research overview →
Cited research
- Sikiric P, Hahm KB, Blagaic AB, et al Gut and Liver. 2020. PMID: 31158953.
- Seiwerth S, Milavic M, Vukojevic J, et al Frontiers in Pharmacology. 2021. PMID: 34267654.
- Brcic L, Brcic I, Staresinic M, Novinscak T, Sikiric P, Seiwerth S Journal of Physiology and Pharmacology. 2009. PMID: 20388964.
- Vasireddi N, et al HSS Journal. 2025. PMID: 40756949.
Primary literature, verified against PubMed. Cited for scientific reference only — no human-use indication is implied.
The finer
details.
Check the product format, available strengths and intended use.
- Product
- BPC-157 10MG
- Intended use
- Laboratory research only
- Documentation
- See COA tab for strength and batch reports
Read the report.
Know the batch.
Compare the product, strength and batch on your vial with the original laboratory document.
Lazarus batch report
- Batch
- LL-BPC157-0125
- Report
- #110530
- Tested
- 2026-08-07
- Reported purity
- 97.971%
Reports identify tested batches. The available reports do not establish which batch will be dispatched with your order.
WA dispatch.
Tracked delivery.
Orders are dispatched from Western Australia with tracking. Check the selected product's availability and any pre-order notice before ordering.
Pre-order items follow their stated dispatch estimate. Orders containing pre-order items ship together once everything is available.
Shipping details →
